Type 2 Nation – A New Hope to Restore Eyesight

The device, created by Dr. Isaac Lipshitz, CEO of OptoLight Vision Technology in Israel, restores vision lost through end-stage age-related macular degeneration. The U.S. Food and Drug Administration (FDA) recently revised its criteria regarding which patients can use this treatment

Read more

Posted in Type II Medical Research